1 – 10 of 49
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        Revisiting substance P in migraine : a methodological approach inspired by anti-CGRP and anti-PACAP success
    
    - Contribution to journal › Article
 
- 
                        Mark
        Gepants
    (2025) p.295-304- Chapter in Book/Report/Conference proceeding › Book chapter
 
- 2024
- 
                        Mark
        Sex differences in expression of CGRP family of receptors and ligands in the rat trigeminal system
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        Progesterone distribution in the trigeminal system and its role to modulate sensory neurotransmission : influence of sex
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors
    
    - Contribution to journal › Article
 
- 
                        Mark
        Dual action of the cannabinoid receptor 1 ligand arachidonyl-2′-chloroethylamide on calcitonin gene-related peptide release
    
    - Contribution to journal › Article
 
- 
                        Mark
        Could Experimental Inflammation Provide Better Understanding of Migraines?
    
    - Contribution to journal › Scientific review
 
- 2021
- 
                        Mark
        Neurokinins and their receptors in the rat trigeminal system : Differential localization and release with implications for migraine pain
    
    - Contribution to journal › Article
 
- 
                        Mark
        CGRP and migraine; from bench to bedside
    
    - Contribution to journal › Scientific review
 
- 2020
- 
                        Mark
        Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
    
    - Contribution to journal › Letter
 
